Clinical trial
Evaluating the Use of the FiberNet Embolic Protection System in Carotid Artery Stenting: The EPIC US Pivotal Study.
NCT00460187 is registered in ClinicalTrials.gov with Lumen Biomedical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Use of the FiberNet Embolic Protection System in Carotid Artery Stenting: The EPIC US Pivotal Study.
- Lead sponsor
- Lumen Biomedical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2007
- Completion date
- June 30, 2008
- Enrollment
- 237 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
percutaneous intervention of the carotid arteries.